Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89a6bd4a27bd6c2955f6a169fe0cb689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aecc858af3148332ea7d3579cb3f084c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28cbf1d993ef2e41dbba532b939078ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7aeca392c7b281e1c63f7bcb4589ff7 |
publicationDate |
2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2016016419-A |
titleOfInvention |
CONJUGATES AND COMPOSITIONS OF TEXAFIRINA-PT (IV) FOR USE TO EXCEED THE RESISTANCE OF THE PLATINUM. |
abstract |
The present description relates to conjugates linked to platinum (IV) and texaphyrin and compositions comprising texaphyrin and a platinum (IV) agent. The present description also provides pharmaceutical compositions of said conjugates and compositions. Also, methods of using the present compounds in the treatment of cancer such as platinum resistant cancer are provided. |
priorityDate |
2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |